Article info

Download PDFPDF
LyGDI is a Promising Biomarker for Ovarian Cancer


  1. Address correspondence and reprint requests to Xiaowei Zhang, MD, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China. E-mail: zhangxw{at}; and Lijun Ma, MD, Department of Oncology, Shanghai Jiaotong University Renji Hospital, Shanghai, China.


Zhen H, Yang S, Wu H, et al
LyGDI is a Promising Biomarker for Ovarian Cancer

Publication history

  • Received October 29, 2009
  • First published April 1, 2010.
Online issue publication 
April 01, 2010

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.